Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say ...

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.

The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing ...

Shares of Weight Watchers parent company WW International (WW) rose nearly 40% after the company announced plans to begin ...

In addition to availability, the cost of weight loss drugs like Wegovy and Zepbound is a major barrier preventing many ...

A survey of employers finds that only about a fifth of large companies cover drugs like Wegovy for weight loss. A majority of companies that do cover the medicines have requirements.

In a trial called SURMOUNT-5, Lilly enrolled 700 people in an attempt to prove Zepbound is better than Wegovy at reducing the body mass of people with obesity or who are overweight, and have another ...

Shares of WeightWatchers parent company WW International ($WW) have rocketed 40% higher on news that the company plans to ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...

WeightWatchers stock rises after the company announces compounded semaglutide offerings, addressing GLP-1 shortages while ...

High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...